Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion type Assertion NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_head.
- NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion description "[With the recognition that PCFT is abundantly expressed in human tumors and is active at pHs characterizing the tumor microenvironment, attention turned to exploiting PCFT for delivering novel cytotoxic antifolates for solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_provenance.
- NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion evidence source_evidence_literature NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_provenance.
- NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion SIO_000772 22954694 NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_provenance.
- NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion wasDerivedFrom befree-2016 NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_provenance.
- NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_assertion wasGeneratedBy ECO_0000203 NP1010828.RA6j-bceL64GvbgRVPTkiVM6HqpF8b8evw07jaNsb6v90130_provenance.